Objective
Cebiotex is a company founded by medical business entrepreneurs plus experts from the biomedical nano-fibre plus oncology sectors. With experts from a world leading hospital in cancer treatment(Sant Joan de Déu) and researchers from the Universitat Politecnica de Catalunya, we have been steadily developing our technology and single minded vision for several years.
Our patented process allows for a unique method for depositing of active agents between nano-fibres. The resultant flexible, biodegradable nano-gauze will be able to radically improve treatments across multiple fields. Our first product line uses the highly potent and promising anti-cancer drug, SN-38. Until now, the low solubility of a drug such as SN-38 has withheld its adoption because standard drug delivery mechanisms fail. We turn the problem on its head, using our proprietary gauze we hold the active agent in place next to the treatment area, taking advantage of the low solubility of such drugs to provide constant high dosage to targeted cells over 4 weeks.
With a focus on this initial cancer cell therapy control drug, we have a vision to use this as a spearhead to firmly plant ourselves in the European medical biotech sector.
We request targeted SME Instrument funding in order to fully prepare the commercial groundwork for our vision to become a leading drug delivery platform organisation and to finalise plans to move our first product from pre-clinical to phase I/II trials. By challenging all of our assumptions we wish to confirm our predictions for a solid business, solid employment growth and a new nano-tech drug development specialism in Europe.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- medical and health sciences basic medicine pharmacology and pharmacy drug discovery
- social sciences economics and business business and management entrepreneurship
- social sciences economics and business business and management business models
- medical and health sciences clinical medicine oncology
- medical and health sciences medical biotechnology cells technologies
You need to log in or register to use this function
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and well-being
MAIN PROGRAMME
See all projects funded under this programme -
H2020-EU.3.1.3. - Treating and managing disease
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
SME-1 - SME instrument phase 1
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) H2020-SMEInst-2016-2017
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
08028 BARCELONA
Spain
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.